CN100381175C - Microemulsion formulation and its preparation process - Google Patents
Microemulsion formulation and its preparation process Download PDFInfo
- Publication number
- CN100381175C CN100381175C CNB2005101080127A CN200510108012A CN100381175C CN 100381175 C CN100381175 C CN 100381175C CN B2005101080127 A CNB2005101080127 A CN B2005101080127A CN 200510108012 A CN200510108012 A CN 200510108012A CN 100381175 C CN100381175 C CN 100381175C
- Authority
- CN
- China
- Prior art keywords
- water
- microemulsion
- proportion
- microemulsion formulation
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The present invention discloses a micro emulsion formulation and a preparation process thereof, particularly a micro emulsion formulation with active components of Chinese medicines and a preparation process thereof. The micro emulsion formulation is composed of a surface active agent, an assistant surface active agent, an oil phase and a water phase, wherein the oil phase comprises volatile oil extracted by a single medicine and/or a compound Chinese medicine; the water phase comprises water extracting solution by the single medicine and/or the compound Chinese medicine. One or a plurality of solid active substances of the Chinese medicines can also be added in the micro emulsion formulation. The micro emulsion technique of the present invention provides a Chinese medicine formulation with a new medicine carrying system. The micro emulsion formulation enhances the dissolvability of medicines with difficult solubility, and enhances the biological availability of the medicines. Micro emulsion can simultaneously contain different fatsoluble medicines for enhancing the stability of some unstable medicines.
Description
Invention field
The present invention relates to a kind of microemulsion formulation and preparation method thereof, particularly a kind of microemulsion formulation that contains active ingredient of Chinese herbs and preparation method thereof.
Background technology
The microemulsion structure is found in nineteen forty-three first by Englishize scholar Sculman and Hoar.And formally name in nineteen fifty-nine and to be microemulsion (microemulsion).The microemulsion structure is the homogeneous system of thermodynamically stable oily one water-surfactant-cosurfactant, and appearance transparent or approximate transparent also equally is divided into W/O and O/W type with general Emulsion, particle diameter is little, usually between 10-100nm, thus also be referred to as microemulsion (Nanoemulsion, NE).This special construction of microemulsion is all being obtained suitable progress in a lot of fields, it is important and be very active branch to become of surface chemistry.Micro-emulsion technology has been penetrated into fields such as daily-use chemical industry, fine chemistry industry, petrochemical industry, material science, biotechnology and environmental science, becomes current popular, that have the huge applications potentiality in the world research field.Microemulsion also causes people's attention gradually as the application of pharmaceutical carrier, and microemulsion has great application potential as a kind of new drug carrier.Cyclosporin, cancer therapy drug camptothecine, antipyretic and anti-inflammatory medicine indometacin cloth, the fragrant monooctyl ester micro-emulsion injecta in Lip river, flurbiprofen injection or the like all have the result to show, and above medicine is made after the microemulsion formulation, and dissolubility obviously improves, and bioavailability increases greatly.Microemulsion is used as pharmaceutical carrier bigger potentiality and wide prospect, but at the field of Chinese medicines, domestic and international research does not seldom still have the product appearance of Chinese medicine microemulsion formulation now, and it is to have a extensive future and far reaching work that microemulsion formulation is applied to the field of Chinese medicines.
Summary of the invention
The object of the invention is to provide a kind of microemulsion formulation and preparation method thereof, and a kind of microemulsion formulation that contains active ingredient of Chinese herbs and preparation method thereof is provided especially.
Microemulsion formulation of the present invention is by surfactant, cosurfactant, oil phase, water four phase compositions, and the proportion relation of surfactant, cosurfactant, oil phase, water four phases is: 1-10: 1-20: 0.2-5: 0.5-15.
Best proportion relation is: 10: 20: 1: 10; 10: 20: 2: 10; 5.5: 2: 2.5: 0.5; 6: 3: 2.5: 1; 5: 20: 1: 15.
When above-mentioned surfactant, cosurfactant, oil phase or water all were liquid, its ratio unit was a volume ratio; When above-mentioned surfactant, cosurfactant, oil phase or aqueous portion are solid, when part was liquid, its ratio unit was that w/v is L/Kg.
Can also add pharmaceutically active substance in a kind of and/or several solid in above-mentioned microemulsion formulation, the amount that adds pharmaceutically active substance in the solid is to contain conventional effective dose in the microemulsion formulation.
Surfactant in the microemulsion formulation is ionic surfactant or nonionic surfactant, as tween, lecithin, one or more in the polyoxyethylene castor oil; Cosurfactant is a short chain alcohol, and in ethanol, propylene glycol, glycerol, sorbitol etc. one or more; Oil phase is an isopropyl myristate, Oleum Glycines, Oleum Arachidis hypogaeae semen, oleic acid, one or more in the volatilization wet goods that single or herbal mixture extract; Water is a distilled water, one or more in single or the herbal mixture water extract etc.
Single in the oil phase of microemulsion formulation of the present invention or herbal mixture volatile oil comprise the volatile oil that extracts in any single that contains volatile oil and the herbal mixture, as Herba Menthae, and Flos Rosae Rugosae, Radix Angelicae Sinensis, Cortex Magnoliae Officinalis, the Radix Aucklandiae, Flos Carthami, Borneolum Syntheticum, Semen Myristicae, Cortex Cinnamomi, guizhi decoction, Ephedrae Decoction, GEGEN TANG, decoction of four noble drugs, SIWU TANG, in classical Chinese medicine prescription such as Decoction of Four-Drug Juice and the volatile oil that extracts according to the new prescription of forming of theory of Chinese medical science one or more, described volatile oil contains the active ingredient of conventional effective dose;
The Chinese traditional medicine water extract of the aqueous phase of microemulsion formulation of the present invention comprises the water extract that extracts in any single that contains water-soluble components or the herbal mixture, as Herba Menthae, and Flos Rosae Rugosae, Radix Angelicae Sinensis, Cortex Magnoliae Officinalis, the Radix Aucklandiae, Flos Carthami, Borneolum Syntheticum, Semen Myristicae, Cortex Cinnamomi, guizhi decoction, Ephedrae Decoction, GEGEN TANG, decoction of four noble drugs, SIWU TANG, classical Chinese medicine prescription such as Decoction of Four-Drug Juice and according to the new prescription of forming of theory of Chinese medical science extract the water extract in one or more, described water extract contains the active ingredient of conventional effective dose.
When the single in the above-mentioned microemulsion formulation oil phase or herbal mixture volatile oil when being several, the ratio of various volatile oil is equal volume or need carries out proportioning by the tcm clinical practice prescription; When the Chinese traditional medicine water extract of above-mentioned microemulsion formulation aqueous phase when being several, the ratio of various Chinese traditional medicine water extracts is equal volume or need carries out proportioning by the tcm clinical practice prescription.In comprising single or herbal mixture volatile oil in the oil phase of above-mentioned microemulsion formulation when a kind of and/or several, when aqueous phase comprises a kind of and/or several in the Chinese traditional medicine water extract, or when comprising in a kind of and/or several solid pharmaceutically active substance in the microemulsion formulation, the medication rule of combination of above-mentioned volatile oil, water extract or active substance is followed the clinical compatibility principle.
Microemulsion formulation of the present invention is Water-In-Oil (O/W) type or oil-in-water (W/O) type, contains the active ingredient of conventional effective dose in the unit formulation.
The above-mentioned microemulsion formulation of the present invention is meant various clinical acceptable forms, includes but not limited to a kind of in the middle of the following dosage form: as soft capsule, and liquid preparations such as suspensoid, oral liquid, enema, injection.
The preparation method of microemulsion formulation of the present invention is a kind of in the following method:
Under the temperature of 25 degree-65 degree Celsius, get surfactant, cosurfactant, oil phase and water in proportion, mix forming microemulsion formulation.
Under the temperature of 25 degree-65 degree Celsius, get surfactant, cosurfactant, oil phase and water in proportion; Oil phase is dissolved in makes its dissolving in the cosurfactant, under the gentle agitation condition, add surfactant, water and mix and form microemulsion formulation.
The preparation method of the microemulsion formulation of pharmaceutically active substance is a kind of in the following method in the adding solid of the present invention:
Get pharmaceutically active substance in surfactant, cosurfactant, oil phase, water and the solid in proportion; Under the temperature of 25 degree-65 degree Celsius, surfactant, cosurfactant, oil phase, water are mixed the formation microemulsion formulation; Add pharmaceutically active substance in the solid, form the pastille microemulsion formulation.
Get pharmaceutically active substance in surfactant, cosurfactant, oil phase, water and the solid in proportion; Under the temperature of 25 degree-65 degree Celsius, oil phase is dissolved in makes its dissolving in the cosurfactant, under the gentle agitation condition, add surfactant, water and mix and form microemulsion formulation; Add pharmaceutically active substance in the solid, form the pastille microemulsion formulation.
Get pharmaceutically active substance in surfactant, cosurfactant, oil phase, water and the solid in proportion; Under the temperature of 25 degree-65 degree Celsius with solid in pharmaceutically active substance be dissolved in cosurfactant, oil phase and/or aqueous phase and make its dissolving, under the gentle agitation condition, add the surfactant that does not add again, cosurfactant, oil phase and/or water mix the microemulsion formulation that forms pastille.
Pharmaceutically active substance microemulsion preparation method is molten or insoluble and dissolve in active component in alcohol, the wet goods organic solvent applicable to all shipwrecks in the solid of the present invention.Comprise alkaloidss such as Herba Ephedrae alkaloid, Rhizoma Coptidis alkaloid, Rhizoma Corydalis alkaloid, matrine, andrographolide (diterpene); Arteannuin (sesquiterpene); Paclitaxel (diterpene); Toosendanin (triterpene); Bilobalide (diterpene); Solatene terpenoid such as (tetraterpenes), Radix Ginseng total saponins, saponinss such as arasaponin, Radix Salviae Miltiorrhizae flavone, flavonoids such as Radix Puerariae flavone, tea polyphenols; Polysaccharides such as Polyphenols such as agrimonine and astragalus polysaccharides, ginseng polysaccharide.
In the above-mentioned microemulsion formulation, when oil phase was in the volatile oil that extracts of single or herbal mixture one or more, the preparation method of its volatile oil was to extract total volatile oil and/or volatile oil with conventional method from unit and/or herbal mixture; When water in the microemulsion formulation was in single or the herbal mixture water extract one or more, the preparation method of its water extract was to extract aqueous extract with conventional method from unit and/or herbal mixture, and aqueous extract should be through the filtration clarifying treatment of routine.
Microemulsion technology of the present invention provides new medicine-carried system for Chinese medicine preparation, and described microemulsion formulation can improve the dissolubility of insoluble drug, promotes the macromolecule water-solubility medicine in the intravital absorption of people, improves these bioavailability of medicament; Microemulsion can contain different fat-soluble medicines simultaneously, improves the stability of some labile drugs;
Because the particle diameter of microemulsion is little and even, makes the medicine dispersion height that is encapsulated in wherein, has promoted the Transdermal absorption of medicine; Microemulsion formulation viscosity of the present invention is low, and particle diameter is little, can be used as injection, and injection can not cause pain; The medicine that is easy to hydrolysis is made the water-in-oil type microemulsion effectively restrain its hydrolysis, play a protective role; Microemulsion formulation of the present invention has prolonged the drug release time of water soluble drug; Microemulsion formulation preparation method of the present invention is simple, and preparation has the transparency liquid of each homogeny, Thermodynamically stable, and particle diameter is little, can filter, and is easy to preparation and preservation.
Following experimental example is used for explanation but is not limited to the present invention.
Experimental example 1: the investigation of the physicochemical property of andrographolide microemulsion formulation
Assay: the content of measuring andrographolide in the andrographolide microemulsion formulation with the HPLC method.Mobile phase is that the content that methanol-water (50: 50) records andrographolide is 7.8447mg/ml.
The mensuration of heat stability: the andrographolide microemulsion was at room temperature placed 30 days, observed its clarity, and regularly surveyed its OD value, and the result shows under the andrographolide microemulsion formulation room temperature and has good stability, no lamination, and the OD value did not have significant difference in 30 days.In addition, at 40 ℃, 60 ℃, 80 ℃ of constant temperature were placed 10 days, observed its outward appearance every day, and in 1,3, measured its OD value respectively in 5,7,10 days with the lactone breast, and the result shows that the andrographolide microemulsion formulation at high temperature also has good stable.
Particle size determination:, obtain its particle size range between 30-60nm with the particle diameter of transmission electron microscope observing andrographolide microemulsion formulation and the measurement of taking pictures.
Andrographolide has fine solubility in microemulsion.Andrographolide is water-soluble hardly, and is solvable in ethanol, and dissolubility is fine in microemulsion, 8 milliliters of andrographolide of solubilized in every milliliter of microemulsion.
Experimental example 2: andrographolide microemulsion formulation pharmacodynamics is tentatively investigated
Andrographolide microemulsion formulation and andrographolide sheet are carried out pharmacodynamics relatively, and the result shows, the andrographolide microemulsion causes in the toes swelling experiment suppressing rat Ovum Gallus domesticus album, and effect obviously is better than the andrographolide sheet, shows as rapid-actionly, and action effect is obvious.
The andrographolide microemulsion is to the influence of toes swelling due to the rat Ovum Gallus domesticus album
* compares p＜0.01 with blank group; ## and aspirin group be p＜0.01 relatively; ^^ and andrographolide sheet group be p＜0.01 relatively.
Experimental example 3: the extraction efficiency comparative test of microemulsion
Get tween 80, ethanol, isopropyl myristate, distilled water, ratio is 5: 20: 1: 15, be mixed with the blank microemulsion of 500ml, and get 100g Herba Andrographis, flooded 4 days with blank microemulsion, filter impregnation liquid, get the microemulsion extracting solution.Other gets 65% ethanol 500ml, gets 100g Herba Andrographis, uses alcohol dipping 4 days, filters impregnation liquid, gets ethanol extract.Measure the content of andrographolide in two kinds of extracting solution respectively, wherein the yield of microemulsion extracting solution is 0.08%, and the yield of ethanol extract is 0.06%, and the extraction efficiency that microemulsion is described is than ethanol height.
Experimental example 4: the investigation of other drug effective ingredient dissolubility in microemulsion
Baicalin dissolubility in water and ethanol is all very poor, and is water-soluble hardly, is slightly soluble in ethanol, but in microemulsion 3.3 milligrams of every milliliter of solubilized.
The specific embodiment is as follows:
Embodiment 1: Borneolum Syntheticum microemulsion capsule
Be 10: 20: 2 in proportion: 10 get tween 80 10L, ethanol 20L, Borneolum Syntheticum 2Kg, distilled water 10L; Get Borneolum Syntheticum and be dissolved in the ethanol, after fully stirring is treated to dissolve fully; Add tween 80 according to aforementioned proportion, distilled water fully stirs; Add conventional other adjuvants and make capsule.
Embodiment 2: the Herba Menthae microemulsion soft capsules
Be 5.5: 2: 2.5 in proportion: 0.5 gets tween 5.5L, ethanol 2L, Oleum menthae 2.5L, aqua methnae extract 0.5L; get Oleum menthae 2.5L; under fully stirring it is dissolved in the 2L ethanol; and then add surfactant in proportion; oil phase; water and other adjuvants, fully stir, make soft capsule and get final product.
Embodiment 3: Herba Menthae microemulsion liniment
Be 5.5: 2: 2.5 in proportion: 20 get tween 5.5L, ethanol 2L, Oleum menthae 2.5L, aqua methnae extract 20L, get Oleum menthae 2.5L, under fully stirring it are dissolved in the 2L ethanol, and then add surfactant in proportion, oil phase, water and other adjuvants, fully stir, make liniment and get final product.
Embodiment 4: the Chinese medicine compound collateral dredging is rescued the brain soft capsule
Be 5.5: 2: 2.5 in proportion: 20 get tween 5L, ethanol 5L, collateral dredging rescues volatile oil 2.5L, the collateral dredging that the brain compound recipe extracts and rescues the water extract 20L that the brain compound recipe extracts, get collateral dredging and rescue the volatile oil 2.5L that the brain compound recipe extracts, under fully stirring it is dissolved in the 5L ethanol, and then add surfactant in proportion, oil phase, water and other adjuvants fully stir, and make soft capsule.
Embodiment 5: Flos Rosae Rugosae microemulsion liniment
Be 6: 3: 2.5 in proportion: 1 gets tween 6L, ethanol 3L, Oleum Rosae Rugosae 5L, rose water extract 1L, gets Oleum Rosae Rugosae 5L, under fully stirring it is dissolved in the 3L ethanol, and then add surfactant in proportion, oil phase, water and other adjuvants are made liniment after fully stirring..
Embodiment 6: Flos Rosae Rugosae microemulsion cream
Be 6: 3: 2.5 in proportion: 20 get tween 6L, ethanol 3L, Oleum Rosae Rugosae 2.5L, rose water extract 20L, get Oleum Rosae Rugosae 2.5L, make it be dissolved in 3L ethanol under fully stirring, and then add surfactant in proportion, oil phase, water and other adjuvants are made cream after fully stirring..
Embodiment 7:Radix Angelicae Sinensis microemulsion capsule
Be 5: 20: 0.2 in proportion: 10 get the volatile oil 0.2L of tween 80 5L, ethanol 20L, Radix Angelicae Sinensis extraction, the water extract 10L that Radix Angelicae Sinensis extracts, get Radix Angelicae Sinensis volatile oil, make it be dissolved in ethanol under fully stirring, add surfactant then in proportion, water and other adjuvants, encapsulated after fully stirring..
Concrete operations are as follows:
Get Radix Angelicae Sinensis 50Kg, steam distillation extracts volatile oil 0.2L; Aqueous solution after the extraction is concentrated into 100L, adds 95% ethanol 200L, stirs, and standing over night is filtered, and filtrate is concentrated into 10L, adds volatile oil 0.2L in the filtrate respectively, ethanol 20L, and tween 80 5L fully stirs, and makes soft capsule.
Embodiment 8:Rhizoma Chuanxiong microemulsion capsule
Be 10: 20: 0.5 in proportion: 20 get the volatile oil 0.5L of tween 80 10L, ethanol 20L, Rhizoma Chuanxiong extraction, the water extract 20L that Rhizoma Chuanxiong extracts, get Rhizoma Chuanxiong volatile oil 0.5L, under fully stirring it is dissolved in the 20L ethanol, add surfactant then in proportion, water and other adjuvants, encapsulated after fully stirring.
Embodiment 9:Foshousan microemulsion capsule
Be 5: 10: 0.6 in proportion: the water extract 20L that 20 volatile oil 0.6L, Radix Angelicae Sinensis and the Rhizoma Chuanxiongs of getting tween 80 5L, ethanol 10L, Radix Angelicae Sinensis (18Kg) and Rhizoma Chuanxiong (12Kg) extraction extract, get the volatile oil of extraction, under fully stirring it is dissolved in the 10L ethanol, add surfactant then in proportion, water and other adjuvants, encapsulated after fully stirring.
Embodiment 10:Liang Fu Wan microemulsion capsule
Be 10: 5: 1 in proportion: the water extract 20L that 20 volatile oil 1L, Rhizoma Alpiniae Officinarum and the Rhizoma Cyperis of getting tween 80 10L, ethanol 5L, Rhizoma Alpiniae Officinarum (500Kg) and Rhizoma Cyperi (500Kg) extraction are extracted, get the volatile oil of extraction, under fully stirring it is dissolved in the 5L ethanol, add surfactant then in proportion, water and other adjuvants, encapsulated after fully stirring.
Embodiment 11: the andrographolide microemulsion soft capsules
Be 10: 20: 1 in proportion: 10 get tween 80 10L, ethanol 20L, isopropyl myristate 1L, distilled water 10L, get andrographolide 320Kg, place the 20L dehydrated alcohol, fully stir, ultrasonic short molten, treat to dissolve fully the back and add surfactant, oil phase and water and other adjuvants, fully stir the back packing and make capsule according to aforementioned proportion.
Embodiment 12: andrographolide microemulsion capsule
Be 5: 20: 1 in proportion: 15 get tween 80 5L, ethanol 20L, isopropyl myristate 1L, distilled water 15L, get andrographolide 320Kg, be dissolved in the 20L ethanol, after fully stirring is treated to dissolve fully, add surfactant according to aforementioned proportion, oil phase, water and other adjuvants, fully stir, make capsule.
Embodiment 13: arasaponin microemulsion capsule
Be 10: 20: 1 in proportion: 15 get tween 80 10L, ethanol 20L, isopropyl myristate 1L, distilled water 15L, get arasaponin 10g, be dissolved in the 20L ethanol, after fully stirring is treated to dissolve fully, add surfactant according to aforementioned proportion, oil phase, water and other adjuvants, fully stir, make capsule.
Embodiment 14: arasaponin microemulsion capsule
Be 6: 2.5: 1.1 in proportion: 10 get tween 80 6L, sorbitol 2.5Kg, Oleum Glycines 1.1L, distilled water 10L; Get arasaponin 8g, under fully stirring it is dissolved in the 10L distilled water, and then adds surfactant in proportion, cosurfactant, oil phase and other adjuvants, encapsulated after fully stirring.
Embodiment 15: the microemulsion containing matrine capsule
Be 2: 3: 0.5 in proportion: 12; Get polyoxyethylene castor oil 2L, ethanol 3L, Oleum Arachidis hypogaeae semen 0.5L, distilled water 12L; Get matrine 5.5g, under fully stirring it is dissolved in the 12L distilled water; And then add polyoxyethylene castor oil in proportion, and ethanol, Oleum Arachidis hypogaeae semen adds conventional other adjuvants and makes capsule.
Embodiment 16: Radix Paeoniae Alba total glucosides microemulsion capsule
Be 3: 3: 1.5 in proportion: 10 get lecithin 3L, ethanol 3L, oleic acid 1.5L, distilled water 10L, get Radix Paeoniae Alba total glucosides 0.85g, under fully stirring it are dissolved in the 10L water, and then add surfactant in proportion, cosurfactant, oil phase and other adjuvants, encapsulated after fully stirring.
Embodiment 17: TANSHINONES microemulsion capsule
Be 10: 5: 2 in proportion: 10 get polyoxyethylene castor oil 10L, propylene glycol 5L, Oleum Glycines 2L, distilled water 10L, get TANSHINONES 0.55Kg, make it be dissolved in propylene glycol 5L under fully stirring, and then add surfactant in proportion, oil phase, water and other adjuvants, encapsulated after fully stirring.
Embodiment 18: the arteannuin microemulsion soft capsules
Be 6: 3: 2.5 in proportion: 1 gets tween 6L, ethanol 3L, oleic acid 2.5L, distilled water 1L, gets arteannuin 120g, makes it be dissolved in 3L ethanol under fully stirring, and then add surfactant in proportion, oil phase, water and other adjuvants, fully stir, make soft capsule.
Embodiment 19: the yew alcohol micro-emulsion soft capsule
Be 6: 3: 2.5 in proportion: 1 gets tween 6L, ethanol 3L, oleic acid 2.5L, distilled water 1L, gets paclitaxel 80g, under fully stirring it is dissolved in the 3L ethanol, and then add surfactant in proportion, oil phase, water and other adjuvants, fully stir, make soft capsule.
Embodiment 20:
1: 20: 0.2 in proportion: 15 got tween 1L, ethanol 20L, decoction of four noble drugs volatile oil 0.2L, Xiao Chengqi Tang water extract 10L and peony and licorice decoction water extract 5L, add conventional adjuvant, and soft capsule is made in packing.
Embodiment 21:
1: 1: 5 in proportion: 15 got lecithin 1L, propylene glycol 1L, GEGEN TANG volatile oil 3L and Radix Angelicae Sinensis, Rhizoma Chuanxiong volatile oil 2L, Ramulus Cinnamomi soup extract 15L mixing formation microemulsion, add conventional adjuvant, and suspensoid is made in packing.
Embodiment 22:
1: 20: 5 in proportion: 0.5 got polyoxyethylene castor oil 1L, glycerol 20L, SIWU TANG volatile oil 5L, the very light blue soup extract of Radix Bupleuri 0.5L, mixed to form microemulsion, added conventional adjuvant, and oral liquid is made in packing.
Embodiment 23:
1: 1: 0.2 in proportion: 15 got tween 1L, sorbitol 1Kg, Cortex Cinnamomi volatile oil 0.2L, Borneolum Syntheticum aqueous solution 15L (get 3kg Borneolum Syntheticum be dissolved in the 15L water make), mix forming microemulsion, add conventional adjuvant, and injection is made in packing.
Embodiment 24:
1: 20: 0.2 in proportion: 0.5 got lecithin 1L, ethanol 20L, Semen Myristicae volatile oil 0.2L, Cortex Cinnamomi water extract 0.5L, mixed to form microemulsion, added conventional adjuvant, and enema is made in packing.
Embodiment 25:
1: 1: 5 in proportion: 0.5 got polyoxyethylene castor oil 1L, propylene glycol 1L, Ephedrae Decoction volatile oil 5L, Herba Ephedrae soup extract 0.5L, mixed to form microemulsion, added conventional adjuvant, and oral liquid is made in packing.
Embodiment 26:
1: 20: 5 in proportion: 15 got tween 1L, glycerol 20L, Borneolum Syntheticum 5Kg, saffron aqueous solution 15L, mixed to form microemulsion, added conventional adjuvant, and suspensoid is made in packing.
Embodiment 27:
1: 1: 0.2 in proportion: 0.5 got lecithin 1L, sorbitol 1K g, Flos Carthami volatile oil 0.2L, decoction of four noble drugs water extract 0.5L, mixed to form microemulsion, added conventional adjuvant, and the injection soft capsule is made in packing.
Embodiment 28:
10: 20: 0.2 in proportion: 15 got polyoxyethylene castor oil 10L, ethanol 20L, Decoction of Four-Drug Juice volatile oil 0.2L, Decoction of Four-Drug Juice water extract 15L, mixed to form microemulsion, added conventional adjuvant, and enema is made in packing.
Embodiment 29:
10: 1: 5 in proportion: 15 got tween 10L, propylene glycol 1L, volatile oil of Radix Aucklandiae 5L, Semen Myristicae water extract 15L, mixed to form microemulsion, added conventional adjuvant, and oral liquid is made in packing.
Embodiment 30:
10: 20: 5 in proportion: 0.5 got lecithin 10L, glycerol 20L, Cortex Magnoliae Officinalis volatile oil 5L, Radix Aucklandiae water extract 0.5L, mixed to form microemulsion, added conventional adjuvant, and suspensoid is made in packing.
Embodiment 31:
10: 1: 0.2 in proportion: 15 got polyoxyethylene castor oil 10L, sorbitol 1Kg, guizhi decoction volatile oil 0.2L, YUPINGFENG SAN water extract 15L, mixed to form microemulsion, added conventional adjuvant, and soft capsule is made in packing.
Embodiment 32:
10: 20: 0.2 in proportion: 0.5 got tween 10L, propylene glycol 20L, Radix Angelicae Sinensis volatile oil 0.2L, distilled water 0.5L, mixed to form microemulsion, added conventional adjuvant, and injection is made in packing.
Embodiment 33:
10: 1: 5 in proportion: 0.5 got lecithin 10L, glycerol 1L, oleic acid 5L, Cortex Magnoliae Officinalis water extract 0.5L, mixed to form microemulsion, added conventional adjuvant, and enema is made in packing.
Embodiment 34:
10: 20: 5 in proportion: 15 got polyoxyethylene castor oil 10L, sorbitol 20Kg, Oleum Arachidis hypogaeae semen 5L, Radix Angelicae Sinensis water extract 15L, mixed to form microemulsion, added conventional adjuvant, and oral liquid is made in packing.
Embodiment 35:
10: 1: 0.2 in proportion: 0.5 got lecithin 10L, sorbitol 1L, Oleum Glycines 0.2L, rose water extract 0.5L, mixed to form microemulsion, added conventional adjuvant, and the soft capsule suspensoid is made in packing.
Embodiment 36:
10: 20: 5 in proportion: 15 got polyoxyethylene castor oil 10L, sorbitol 20Kg, Oleum Arachidis hypogaeae semen 5L, Radix Angelicae Sinensis water extract 15L, mixed to form microemulsion, added agrimonine 4Kg again, added conventional adjuvant, and oral liquid is made in packing.
Embodiment 37:
10: 1: 0.2 in proportion: 0.5 got lecithin 10L, sorbitol 1Kg, Oleum Glycines 0.2L, rose water extract 0.5L, mixed to form microemulsion, added astragalus polysaccharides 100g again, added conventional adjuvant, and the soft capsule suspensoid is made in packing.
Embodiment 38:
10: 20: 0.2 in proportion: 0.5 got tween 10L, propylene glycol 20L, Radix Angelicae Sinensis volatile oil 0.2L, distilled water 0.5L, Radix Angelicae Sinensis volatile oil 0.2L is dissolved among the propylene glycol 20L, add tween 10L, distilled water 0.5L, matrine 100g again, add conventional adjuvant, injection is made in packing.
Embodiment 39:
10: 1: 5 in proportion: 0.5 got lecithin 10L, glycerol 1L, oleic acid 5L, Cortex Magnoliae Officinalis water extract 0.5L, oleic acid 5L is dissolved among the glycerol 1L, add lecithin 10L, Cortex Magnoliae Officinalis water extract 0.5L, solatene 20g mixing formation microemulsion again, add conventional adjuvant, enema is made in packing.
Embodiment 40:
Be 10: 20: 1 in proportion: 10 get tween 80 10L, ethanol 20L, isopropyl myristate 1L, distilled water 10L, mix to form microemulsion, add Quercetin 0.6Kg again, and arteannuin 0.5Kg adds conventional adjuvant, and capsule is made in packing.
Embodiment 41:Liujunzi Tang microemulsion capsule
Liujunzi Tang: Radix Ginseng (9 gram) Rhizoma Atractylodis Macrocephalae (9 gram) Poria (9 gram) Radix Glycyrrhizae Preparata (6 gram) Pericarpium Citri Reticulatae (3 gram) Rhizoma Pinelliae (4.5 gram)
Volatile oil in the Liujunzi Tang can be prepared by following method: get Rhizoma Atractylodis Macrocephalae 9kg, Pericarpium Citri Reticulatae 3kg, Rhizoma Pinelliae 4.5kg, place volatile oil extractor to extract volatile oil 0.8L;
Water extract in the Liujunzi Tang can be prepared by following method: get Radix Ginseng 9kg, Poria 9kg, Radix Glycyrrhizae Preparata 6kg, extract with distilled water 100L, extracting solution 20L adds 65% ethanol 100L, leaves standstill, and filters, and filtrate is concentrated into 10L;
10: 20: 0.8 in proportion: 10 got tween 80 10L, ethanol 20L, the volatile oil 0.8L in the Liujunzi Tang; Water extract 10L in the Liujunzi Tang; Volatile oil in the Liujunzi Tang is dissolved in the ethanol, adds tween 80 more respectively, the water extract in the Liujunzi Tang mixes forming microemulsion, adds conventional dressing, encapsulated getting final product.
Embodiment 42:The compound Chinese angelica-root microemulsion capsule that looses
Compound Chinese angelica-root looses: Radix Angelicae Sinensis 9 grams, Rhizoma Chuanxiong 9 grams, the Radix Paeoniae Alba 20 grams, Poria 12 grams, the Rhizoma Atractylodis Macrocephalae 12 grams, Rhizoma Alismatis 9 grams
Volatile oil during compound Chinese angelica-root looses can be prepared by following method: get Radix Angelicae Sinensis 9kg, Rhizoma Chuanxiong 9kg, Rhizoma Atractylodis Macrocephalae 12kg, extract volatile oil with steam distillation respectively, getting Radix Angelicae Sinensis volatile oil is 0.18L, Rhizoma Chuanxiong volatile oil 0.2L, Rhizoma Atractylodis Macrocephalae volatile oil 0.3L;
Water extract during compound Chinese angelica-root looses can be prepared by following method: get Radix Paeoniae Alba 20kg, and Poria 12kg, Rhizoma Alismatis 9kg uses 6 times of water extraction respectively, and precipitate with ethanol is concentrated into 10L more respectively;
10: 20: 0.18 in proportion: 0.2: 0.3: 10: get tween 80 at 10: 10, ethanol, above-mentioned Radix Angelicae Sinensis volatile oil 0.18L, Rhizoma Chuanxiong volatile oil 0.2L, Rhizoma Atractylodis Macrocephalae volatile oil 0.3L, Radix Paeoniae Alba water extract 10L, Poria water extract 10L, Rhizoma Alismatis water extract 10L; Earlier three kinds of volatile oil all are dissolved in ethanol; Add tween 80 and three kinds of medicine water extracts again, be stirred to evenly, form microemulsion; Add conventional dressing, make capsule.
Claims (9)
1. microemulsion formulation of forming by surfactant, cosurfactant, oil phase, water, it is characterized in that surfactant: cosurfactant: oil phase: water is 1-10: 1-20: 0.2-5: 0.5-15; Described oil phase is a kind of and/or several in the volatile oil that extracts of single or herbal mixture; Described water is a kind of and/or several in single or the herbal mixture water extract.
2. microemulsion formulation as claimed in claim 1, the proportion relation that it is characterized in that surfactant, cosurfactant, oil phase, water is 5: 20: 1: 15.
3. microemulsion formulation as claimed in claim 1, the proportion relation that it is characterized in that surfactant, cosurfactant, oil phase, water is 10: 20: 1: 10.
4. microemulsion formulation as claimed in claim 1, the proportion relation that it is characterized in that surfactant, cosurfactant, oil phase, water is 10: 20: 2: 10.
5. microemulsion formulation as claimed in claim 1, the proportion relation that it is characterized in that surfactant, cosurfactant, oil phase, water is 5.5: 2: 2.5: 0.5.
6. microemulsion formulation as claimed in claim 1, the proportion relation that it is characterized in that surfactant, cosurfactant, oil phase, water is 6: 3: 2.5: 1.
7. microemulsion formulation as claimed in claim 1 is characterized in that this microemulsion formulation by the volatile oil of tween 80, ethanol, Radix Angelicae Sinensis extraction, the water extract that Radix Angelicae Sinensis extracts, and be 5: 20: 0.2 by volume: 10 make.
8. microemulsion formulation as claimed in claim 1 is characterized in that this microemulsion formulation by the volatile oil of tween 80, ethanol, Rhizoma Chuanxiong extraction, the water extract that Rhizoma Chuanxiong extracts, and be 10: 20: 0.5 by volume: 20 make.
9. as the arbitrary described microemulsion formulation of claim 1-6, it is characterized in that according to a conventional method described microemulsion formulation being made soft capsule, suspensoid, oral liquid, enema or injection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101080127A CN100381175C (en) | 2004-10-09 | 2005-10-09 | Microemulsion formulation and its preparation process |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200410080436.2 | 2004-10-09 | ||
| CN200410080436 | 2004-10-09 | ||
| CNB2005101080127A CN100381175C (en) | 2004-10-09 | 2005-10-09 | Microemulsion formulation and its preparation process |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007101951983A Division CN101185638B (en) | 2004-10-09 | 2005-10-09 | Microemulsion preparation and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1762333A CN1762333A (en) | 2006-04-26 |
| CN100381175C true CN100381175C (en) | 2008-04-16 |
Family
ID=36746795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005101080127A Active CN100381175C (en) | 2004-10-09 | 2005-10-09 | Microemulsion formulation and its preparation process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100381175C (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1895222B (en) * | 2006-06-16 | 2012-01-11 | 齐红 | Production and use for micro-emulsion and its medicine-carrier preparation |
| CN102100741B (en) * | 2009-12-18 | 2013-03-13 | 中国科学院大连化学物理研究所 | Total tanshinone composite preparation |
| CN102462660A (en) * | 2010-08-16 | 2012-05-23 | 重庆富进生物医药有限公司 | Preparation and application of oil-in-water emulsion of borneol |
| CN102688151B (en) * | 2012-06-05 | 2013-11-20 | 东南大学 | Tanshinone microemulsion and preparation method thereof |
| CN103493846A (en) * | 2013-09-29 | 2014-01-08 | 上海莱博生物科技有限公司 | Preparation method for natural preservative micro-emulsion preparation |
| AU2015308878A1 (en) * | 2014-08-27 | 2017-03-02 | Abbvie Inc. | Topical formulation |
| US11773106B2 (en) | 2015-10-16 | 2023-10-03 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US11524964B2 (en) | 2015-10-16 | 2022-12-13 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US10550126B2 (en) | 2015-10-16 | 2020-02-04 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| CN116284011A (en) | 2015-10-16 | 2023-06-23 | 艾伯维公司 | Process for preparing imidazo [1,2-a ] pyrrolo [2,3-e ] pyrazines and solid forms thereof |
| US11365198B2 (en) | 2015-10-16 | 2022-06-21 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US11512092B2 (en) | 2015-10-16 | 2022-11-29 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| CN105902493B (en) * | 2016-06-03 | 2018-10-26 | 山西中医学院 | A kind of bone-strengthening musk micro emulsion and preparation method thereof |
| US11564922B2 (en) | 2017-03-09 | 2023-01-31 | Abbvie Inc. | Methods of treating crohn's disease and ulcerative colitis |
| EP3592353A1 (en) | 2017-03-09 | 2020-01-15 | AbbVie Inc. | Methods of treating crohn's disease and ulcerative colitis |
| CN107243020B (en) * | 2017-06-26 | 2021-04-02 | 深圳海王医药科技研究院有限公司 | Traditional Chinese medicine oral liquid for treating swelling and pain in throat of children and preparation method thereof |
| CN109329702B (en) * | 2018-11-30 | 2022-05-03 | 浙江工商大学 | Compound bactericide of plant extract and preparation method thereof |
| CN110200833A (en) * | 2019-06-03 | 2019-09-06 | 五邑大学 | A kind of phloretin nano-emulsion preparation and its preparation method and application |
| CN113827563B (en) * | 2021-11-02 | 2023-05-12 | 澳门大学 | Nanoemulsion preparation for treating migraine and preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1161652A (en) * | 1994-10-26 | 1997-10-08 | 诺瓦蒂斯有限公司 | Pharmaceutical compositions |
| CN1252711A (en) * | 1997-04-18 | 2000-05-10 | 大正制药株式会社 | Microemulsion |
| CN1316898A (en) * | 1999-07-05 | 2001-10-10 | 韩美药品工业株式会社 | Oral micro-emulsion composition of silybin |
| CN1449742A (en) * | 2003-05-14 | 2003-10-22 | 沈阳药科大学 | Insoluble medicine transdemal absorption preparation and process for preparing same |
-
2005
- 2005-10-09 CN CNB2005101080127A patent/CN100381175C/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1161652A (en) * | 1994-10-26 | 1997-10-08 | 诺瓦蒂斯有限公司 | Pharmaceutical compositions |
| CN1252711A (en) * | 1997-04-18 | 2000-05-10 | 大正制药株式会社 | Microemulsion |
| CN1316898A (en) * | 1999-07-05 | 2001-10-10 | 韩美药品工业株式会社 | Oral micro-emulsion composition of silybin |
| CN1449742A (en) * | 2003-05-14 | 2003-10-22 | 沈阳药科大学 | Insoluble medicine transdemal absorption preparation and process for preparing same |
Non-Patent Citations (4)
| Title |
|---|
| 丹参酮微乳的制备及其质量评价. 张宁等.中国中药杂志，第28卷第11期. 2003 * |
| 微乳制剂的研究进展. 王红喜等.国外医学药学分册，第23卷第4期. 1996 * |
| 微乳在现代药剂学中的研究进展. 陈华兵等.中国医药工业杂志，第35卷第8期. 2004 * |
| 非离子型表面活性剂微乳的基础研究. 王晓黎等.解放军药学学报，第17卷第6期. 2001 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1762333A (en) | 2006-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100381175C (en) | Microemulsion formulation and its preparation process | |
| CN101185638B (en) | Microemulsion preparation and preparation method thereof | |
| CN1709398B (en) | Filtering-degerming Chinese medicine or animal-plant volatile oil or fat emulsion and preparing method | |
| CN101073606B (en) | Method for separating and extracting white Peony Root | |
| CN1895222B (en) | Production and use for micro-emulsion and its medicine-carrier preparation | |
| CN103372073A (en) | Red rice and hawthorn medicinal composition for regulating blood fat and preparation method of composition | |
| CN103372051A (en) | Red rice and kudzuvine root medicinal composition for regulating blood fat and preparation method of the composition | |
| CN101623475B (en) | Preparation method of Shengui antler oral solid preparation | |
| CN101700266B (en) | Saussurea involucrate nano particles and preparation method and application thereof | |
| CN101658542B (en) | Soft-lithospermum total phenolic acid and use thereof in pharmacy | |
| CN103977336A (en) | Pharmaceutical composition with myocardial ischemia resisting effect and preparation method and application thereof | |
| CN101664452B (en) | Drug combination containing musk | |
| AU2004253211A2 (en) | Matrix adjuvants and the drop pills prepared with them | |
| CN100584356C (en) | Musk containing medicine composition | |
| CN101766699A (en) | Medicinal combination containing musk | |
| CN100584357C (en) | Medicine composition containing borneol and musk | |
| CN101766702B (en) | Medicinal combination containing borneol and musk | |
| CN101766703B (en) | Medicinal combination containing borneol and musk | |
| CN101721444B (en) | Saussurea involucrate self-micro-emulsion, preparation method thereof and application thereof | |
| CN101138612B (en) | Antineoplastic preparations and method of preparing the same | |
| CN101766705B (en) | Medicinal combination containing borneol and musk | |
| CN106389820A (en) | Extraction method for Tianwang buxin dan prescription and Shengmaiyin prescription | |
| CN101766701B (en) | Medicinal combination containing musk | |
| CN101766700B (en) | Medicinal combination containing musk | |
| CN101194941A (en) | Use of microemulsion as Chinese medicine and compound extract dissolvent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHANXI TONGDA PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHANXI TRADITIONAL CHINESE MEDICAL COLLEGE Effective date: 20110513 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 030024 NO. 169, FIRST SECTION OF JINCI ROAD, TAIYUAN CITY, SHANXI PROVINCE TO: 037000 NO. 57, XINJIAN SOUTH ROAD, DATONG CITY, SHANXI PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20110513 Address after: 037000 No. 57, Xinjian South Road, Shanxi, Datong Patentee after: SHANXI TONGDA PHARMACEUTICAL CO., LTD. Address before: 030024 Shanxi city of Taiyuan province Jinci Road 1 No. 169 Patentee before: Shanxi Traditional Chinese Medical College |